A recent study published in the Journal of Attention Disorders provides new evidence that difficult childhood experiences may contribute to symptoms of Attention Deficit/Hyperactivity Disorder (ADHD) ...
In 2019, approximately 40% of oncology patients in the United States were eligible for treatment with immune checkpoint inhibitors (ICIs). Furthermore, it is estimated that one in seven patients who ...
Clinical trials utilize multiple methods of tracking, categorizing, and assessing any side effects at each trial stage. A negative side effect during clinical trials, whether expected as a potential ...
Ipatasertib (IPA) combined with non-taxane chemotherapy (CT) for patients (pts) with previously treated advanced triple-negative breast cancer (aTNBC): The PATHFINDER phase IIa trial. Prognosis and ...
Since its creation in 1990, the U.S. Centers for Disease Control and Prevention’s (CDC) Vaccine Adverse Event Reporting System (VAERS) has provided publicly available data on any adverse reactions ...
Please provide your email address to receive an email when new articles are posted on . The FDA Adverse Event Reporting System will now host daily publications, instead of quarterly. The agency’s goal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback